Extrapulmonary tuberculosis: Tuberculous meningitis new developments

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 4, 2011, Pages 365-386

  Galimi, Rocco ^a  

^a Local Health Unit of Valtellina and Valchiavenna   (Italy)

Author keywords

Antituberculosis agents; Bacillus Calmette Gu rin; Dexamethasone; Extrapulmonary tuberculosis; Human immunodeficiency virus; Mycobacterium tuberculosis; Neurological sequelae; Tuberculous meningitis

Indexed keywords

AMIKACIN; BCG VACCINE; CAPREOMYCIN; CORTICOSTEROID; CYCLOSERINE; DEXAMETHASONE; ETHAMBUTOL; ETHIONAMIDE; GAMMA INTERFERON; GATIFLOXACIN; GLUCOSE; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR;

ANOREXIA; ANTIBIOTIC THERAPY; BACTERIAL TRANSMISSION; BCG VACCINATION; BLOOD BRAIN BARRIER; BRAIN INFARCTION; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; COMA; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CORTICOSTEROID THERAPY; CRANIAL NERVE PARALYSIS; DNA SEQUENCE; DRUG PENETRATION; DRUG RESISTANT TUBERCULOSIS; DRUG TREATMENT FAILURE; EARLY DIAGNOSIS; EXTRAPULMONARY TUBERCULOSIS; FEVER; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HEADACHE; HEMIPARESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; IMMUNE RESPONSE; INCIDENCE; LEUKOCYTOSIS; LUMBAR PUNCTURE; LUNG TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; PHOTOPHOBIA; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RECOMMENDED DRUG DOSE; REVIEW; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULIN TEST; TUBERCULOMA; TUBERCULOSIS; TUBERCULOUS MENINGITIS; TUBERCULOUS SPONDYLITIS; VASCULITIS; VISUAL IMPAIRMENT; VOMITING; WEIGHT REDUCTION;

ANIMALS; ANTITUBERCULAR AGENTS; HUMANS; PROGNOSIS; PUBLIC HEALTH; TUBERCULOSIS, MENINGEAL;

EID: 79955163866     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. WHO. Global tuberculosis control 2009: epidemiology, strategy, financing [WHO/HTM/TB/2009.411].http://www.who.int/entity/tb/publications/global-repor t/2009/pdf/full-repor t.pdf (accessed March 29, 2010).
2. TRENDS IN TUBERCULOSIS-United States, 2007. Morb Mortal Wkly Rep 2008; 57: 281-285.
3. SCHIRMER P, RENAULT CA, HOLODNIY M. Is spinal tuberculosis contagious? Int J Infect Dis 2010; 14: e659-e666
4. MOLLER M, EILEEN G, HOAL EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis 2010; 90: 71-83.
5. ANDERSON NE, WILLOUGHBY EW. Chronic meningitis without predisposing illness-a review of 83 cases. Q J Med 1987; 63: 283-295.
6. THWAITES G, FISHER M, HEMINGWAY C, SCOTT G, SOLOMON T, INNES J. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009; 59: 167-187.
7. DREVETS DA, PIETER JM, LEENEN PJM, GREENFIELD RA. Invasion of the central nervous system by intracellular bacteria. Clin Microbiol Rev 2004; 17: 323-334.
8. HOPEWELL PC. Overview of clinical tuberculosis. In: Bloom BR, editor. Tuberculosis pathogenesis, protection, and control. Washington DC: American Society for Microbiology: 1994; pp. 25-46.
9. SHANKAR P, MANJUNATH N, MOHAN KK, PRASAD K, BEHARI M, SHRINIWAS, AHUJA GK. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet 1991; 1: 5-7.
10. GARG RK. Tuberculous meningitis. Acta Neurol Scand 2010; 122: 75-90.
11. BERENGUER J, MORENO S, LAGUNA F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992; 326: 668-672.
12. BERMAN S, KIBEL MA, FOURIE PB, STREBEL PM. Childhood tuberculosis and tuberculous meningitis: high incidence rates in the Western Cape of South Africa. Tuber Lung Dis 1992; 73: 349-355.
13. FORSSBOHM M, ZWAHLEN M, LODDENKEMPER R, RIEDER HL. Demographic characteristics of patients with extrapulmonary tuberculosis in Germany. Eur Respir J 2008; 31: 99-105.
14. CAILHOL J, CHE D, CAMPESE C, DECLUDT B. Cases of tuberculosis declared in France in 2001. Arch Pediatr 2003; 10: 476-481.
15. CAILHOL J, CHE D, JARLIER V, DECLUDT B, ROBERT J. Incidence of tuberculous meningitis in France, 2000: a capture-recapture analysis. Int J Tuberc Lung Dis 2005; 9: 803-808.
16. PORKERT MT, SOTIR M, PARROTT-MOORE P, BLUMBERG HM. Tuberculous meningitis at a large inner-city medical center. Am J Med Sci 1997; 313: 325-331.
17. WRIGHT A, ZIGNOL M, VAN DEUN A, FALZON D, GERDES SR, FELDMAN K, HOFFNER S, DROBNIEWSKI F, BARRERA L, VAN SOOLINGEN D, BAULABHAL F, PARAMASIVAN CN, KAM KM, MITARAI P, RAVIGLIONE M. Epidemiology of antituberculosis drug resistance 2002- 07: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance. Lancet 2009; 373: 1861-1873.
18. WHO. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti- Tuberculosis Drug Resistance Surveillance. Geneva (Switzerland): WHO; 2008.
19. ISEMAN MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329: 784-791.
20. BYRD TF, DAVIS LE. Multidrug-resistant tuberculous meningitis. Curr Neurol Neurosci Rep 2007; 7: 470-475.
21. SCHAAF H, MARAIS B, HESSELING A, GIE RP, BEYERS N, DONALD PR. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatrica 2006; 95: 523-528.
22. WRIGHT A, ZIGNOL M, VAN DEUN A, FALZON D, GERDES SR, FELDMAN K, HOFFNER S, DROBNIEWSKI F, BARRERA L. VAN SOOLINGEN D, BOULABHAL F, PARAMASIVAN CN, KAM KM, MITARAI S, NUNN P, RAVIGLIONE M. Epidemiology of anti-tuberculosis drug resistance 2002-2007: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009; 368: 2142-2154.
23. NAGARATHNA S, RAFI W, VEENAKUMARI HB, MANI R, SATISHCHANDRA P, CHANDRAMUKI A. Drug susceptibility profiling of tuberculous meningitis. Int J Tuberc Lung Dis 2008; 12: 105-107.
24. EDWARDS D, KIRKPATRICK CH. The immunology of mycobacterial diseases. Am Rev Respir Dis 1986; 134: 1062-1071.
25. DANNENBERG AM. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989; 11: S369-S378.
26. RICH AR, MCCORDOCK HA. The pathogenesis of tuberculous meningitis. Bull John Hopkins Hosp 1933; 52: 5-37.
27. VANKAYALAPATI R, BARNES PF. Innate and adaptive immune responses to human Mycobacterium tuberculosis infection. Tuberculosis 2009; 89: S1: S77-S80.
28. PAI M, MOHAN A, DHEDA K, LEUNG CC, YEW WW, CHRISTOPHER DJ, SHARMA SK. Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther 2007; 5: 385-391.
29. FERNANDO SL, SAUNDERS BM, SLUYTER R, SKARRATT KK, GOLDBERG H, MARKS GB, WILEY JS, BRITTON WJ. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am J Respir Crit Care Med 2007; 175: 360-366.
30. NIÑO-MORENO P, PORTALES-PÉREZ D, HERNÁNDEZ-CASTRO B, PORTALES-CERVANTES L, FLORES-MERAZ V, BARANDA L, GÓMEZ-GÓMEZ A, ACUÑA-ALONZO V, GRANADOS J, GONZÁLEZ-AMARO R. P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis. Clin Exp Immunol 2007; 148: 469-477.
31. HAWN TR, DUNSTAN SJ, THWAITES GE, SIMMONS CP, THUONG NT, LAN NT, QUY HT, CHAU TT, HIEU NT, RODRIGUES S, JANER M, ZHAO LP, HIEN TT, FARRAR JJ, ADEREM A. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J Infect Dis 2006; 194: 1127-1134.
32. STEIN CM, ZALWANGO S, CHIUNDA AB, MILLARD C, LEOTIEV DV, HORVATH AL, CARTIER KC, CHERVENAK K, BOOM WH, ELSTON RC, MUGERWA RD, WHALEN CC, IYENGAR SK. Linkage and association analysis of candidate genes for TB and TNFalpha cytokine expression: evidence for association with IFN-GR1, IL-10 and TNF receptor 1 genes. Hum Genet 2007; 121: 663-673.
33. CAWS M, THWAITES G, DUNSTAN S, HAWN TR, LAN NT, THUONG NT, STEPNIEWSKA K, HUYEN MN, BANG ND, LOC TH, GAGNEUX S, VAN SOOLINGEN D, KREMER K, VAN DER SANDE M, SMALL P, ANH PT, CHINH NT, QUY HT, DUYEN NT, THO DQ, HIEU NT, TOROK E, HIEN TT, DUNG NH, NHU NT, DUY PM, VAN VINH CHAU N, FARRAR J. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PloS Pathog 2008; 4: e1000034.
34. THWAITES G, CAWS M, CHAU TT, D'SA A, LAN NT, HUYEN MN, GAGNEUX S, ANH PT, THO DQ, TOROK E, NHU NT, DUYEN NT, DUY PM, RICHENBERG J, SIMMONS C, HIEN TT, FARRAR J. Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol 2008; 46: 1363-1368.
35. CAWS M, THWAITES G, STEPNIEWSKA K, NGUYEN TN, NGUYEN TH, NGUYEN TP, MAI NT, PHAN MD, TRAN HL, TRAN TH, VAN SOOLINGEN D, KREMER K, NGUYEN VV, NGUYEN TC, FARRAR J. Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol 2006; 44: 3934-3939.
36. DAFFÉ M, DRAPER P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 1998; 39: 131-203.
37. GLICKMAN MS, JACOBS WR. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 2001; 104: 477-485.
38. CHAN J, FAN X, HUNTER SW, BRENNAN PJ, BLOOM BR. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun 1991; 59. 1755-1761.
39. MEENA LS. Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv. FEBS J 2010; 277: 2416-2427.
40. RICH AR. The Pathogenesis of Tuberculosis, 2nd ed. Springfield, IL:, CC Thomas; 1951.
41. DASTUR DK, MANGHANI DK, UDANI PM. Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am 1995; 33: 733-752.
42. MEYES BR. Tuberculous meningitis. Med Clin North Am 1982; 66: 155-162.
43. KLEIN NC, DAMSKR B, HIRSCHMAN SZ. Mycobacterial meningitis: retrospective analysis 1970 to 1983. Am J Med 1985; 79: 29-34.
44. ZUGER A, LOWY FD. TUBERCULOSIS. IN: WM SCHELD, RJ WHITLEY, DT DURACK (EDS), Infections of the Central Nervous System. Philadelphia: Lippincott-Raven 1997: pp. 417-443.
45. HEKTOEN L. The vascular changes in tuberculous meningitis especially in tuberculous endarteritis. J Exp Med 1896; 1: 112e63.
46. LAMMIE AL, HEWLETT RH, JOHAN F. SCHOEMAN JF, DONALD PR.Tuberculous cerebrovascular disease: A review. J Infection 2009; 59: 156e166.
47. SHANKAR P, MANJUNATH N, MOHAN KK, PRASAD K, BEHARI M, SHRINIWAS, AHUJA GK. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet 1991; 1: 5-7.
48. GIRGIS NI, SULTAN Y, FARID Z, MANSOUR MM, ERIAN MW, HANNA LS, MATECZUN AJ. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 1998; 58: 28-34.
49. THWAITES GE, TRAN TH. Tuberculous meningitis: many questions, too few answers. Lancet Neurol 2005; 4: 160-170.
50. CURLESS RG, MITCHELL CD. Central nervous system tuberculosis in children. Pediatr Neurol 1991; 7: 270-274.
51. YARAMI A, GURKAN F, ELEVLI M, SÖKER M, HASPOLAT K, KIRBAŞ G, TAŞ MA. Central nervous system tuberculosis in children: a review of 214 cases. Pediatrics 1998; 102: E49.
52. HANNA LS, GIRGIS NI, ABU EL ELLA AH, FARID Z. Ocular complications in meningitis: "fifteen years study". Metab Pediatr Syst Ophthalmol 1988; 11: 160-162.
53. AMITAVA AK, ALARM S, HUSSAIN R. Neuro-ophthalmicfeatures in pediatric tubercular meningoencephalitis. J Pediatr Ophth Strab 2001; 38: 229-234.
54. BISWAS J, MADHAVAN HN, GOPAL L, BADRINATH SS. Intraocular tuberculosis. Clinicopathologic study of five cases. Retina 1995; 15: 461-468.
55. TANDON PN, BHATIA R, BHARGAVA S. Tuberculous meningitis. In: Harris AA, editor. Handbook of clinical neurology (revised series). Amsterdam: Elsevier Science 1988: pp. 195-226.
56. THOMAS MD, CHOPRA JS, WALIA BNS. Tuberculous meningitis. A clinical study of 232 cases. J Assoc Physicians India 1977; 25: 633-639.
57. KOCEN RS, Parsons M. Neurological complications of tuberculosis: some unusual manifestations. Q J Med 1970; 39: 17-30.
58. HOPEWELL PC. OVERVIEW OF CLINICAL TUBERCULOSIS. IN: BLOOM BR, EDITOR. Tuberculosis pathogenesis, protection, and control. Washington DC: American Society for Microbiology 1994, pp. 25-46.
59. RADHAKRISHNAN K, KIHORE A, MATHURANATH PS. Neurological tuberculosis. In: Sharma SK, Mohan A, editors. Tuberculosis. New Delhi: Jaypee Brothers Medical Publishers 2001: pp. 209-228.
60. TANDON PN, BHATIA R, BHARGAVA S. Tuberculous meningitis. In: Harris AA, editor. Handbook of clinical neurology (revised series). Amsterdam: Elsevier Science 1988 pp. 195-226.
61. GARG RK. Tuberculosis of the central nervous system. Postgrad Med J 1999; 75: 133-140.
62. BONINGTON A, STRANG JI, KLAPPER PE, HOOD SV, PARISH A, SWIFT PJ, DAMBA J, STEVENS H, SAWYER L, ET AL. TB PCR in the early diagnosis of tuberculous meningitis: evaluation of the Roche semi-automated COBAS Amplicor MTB test with reference to the manual Amplicor MTB PCR test. Tuber Lung Dis 200; 80: 191-196.
63. KATRAK SM, SHEMBALKAR PK, BIJWE SR, BHANDARKAR LD. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci 2000; 181: 118-126.
64. DOWDY DW, CHAISSON RE, MOULTON LH, DORMAN SE. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS 2006; 20: 751-762.
65. GIRGIS NI, SULTAN Y, FARID Z, MANSOUR MM, ERIAN MW, HANNA LS, MATECZUN AJ. Tuberculous meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3, Cairo, Egypt from 1976 to 1996. Am J Trop Med Hyg 1998; 58: 28-34.
66. DAVIS LE, RASTOGI KR, LAMBERT LC, SKIPPER BJ. Tuberculous meningitis in the southwest United States: a community-based study. Neurology 1993; 43: 1775-1778.
67. FALLON RJ, KENNEDY DH. Treatment and prognosis in tuberculous meningitis. J Infect 1981; 3: 39-44.
68. KALITA J, MISRA UK. Outcome of tuberculous meningitis at 6 and 12 months: a multiple regression analysis. Int J Tuberc Lung Dis 1999; 3: 261-265.
69. KENNEDY DH, FALLON RJ. Tuberculous meningitis. JAMA 1979; 241: 264-268.
70. STEWART SM. The bacteriological diagnosis of tuberculous meningitis. J Clin Pathol 1953; 6: 241-242.
71. THWAITES GE, HONG CHAU TT, JEREMY J, FARRAR JJ. Improving the bacteriological diagnosis of tuberculous meningits. J Clin Microbiol 2004, 42: 378-379.
72. GARCIA-MONCO JC. Central nervous system tuberculosis. Neurol Clin 1999; 17: 737-759.
73. THWAITES GE, CHAU TT, FARRAR JJ. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 2004; 42: 378-379.
74. SHANKAR P, MANJUNATH N, SHRINIWAS KK, MOHAN K, PRASAD M, BEHARI G, SHRINIWAS, AHUJA GK. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction. Lancet 1991; 337: 5-7.
75. CAWS M, WILSON SM, CLOUGH C, DROBNIEWSKI F. Role of IS6110 targeted PCR, biochemical, clinical and immunological criteria for diagnosis of tuberculous meningitis. J Clin Microbiol 2000; 38: 3150-3155.
76. LACHNIK J, ACKERMANN B, BOHRSSEN A, MAASS S, DIEPHAUS C, PUNCKEN A, STERMANN M, BANGE FC. Rapid cycle PCR and fluorimetry for detection of mycobacteria. J Clin Microbiol 2002; 40: 3364-3373.
77. HEGINBOTHOM ML, MAGEE JT, FLANAGAN PG. Evaluation of the IdahoTechnology Light Cycler PCR for the direct detection of Mycobacterium tuberculosis in respiratory specimens. Int J Tuberc Lung Dis 2003; 7: 78-83.
78. TAKAHASHI T, NAKAYANA T. Novel technique of quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA. J Clin Microbiol 2006; 44: 1029-1039.
79. MAREI AM, EL-BEHEDY EM, MOHTADY HA, AFIFY RF. Evaluation of a rapid bacteriophage-based method for the detection of Mycobacterium tuberculosis in clinical samples. J Med Microbiol 2003; 52: 331-335.
80. ALBAY A, KISA O, BAYLAN O, DOGANIE L. The evaluation of fast plaque TB test for the rapid diagnosis of tuberculosis. Diagn Microbiol Infect Dis 2003; 46: 211-215.
81. HALDAR S, SHARMA N, GUPTA VK, TYAGI JS. Efficient diagnosis of tuberculous meningitis by detection of Mycobacterium tuberculosis DNA in cerebrospinal fluid filtrates using PCR. J Med Microbiol 2009; 58: 616-624.
82. THOMAS MM, HINKS TS, RAGHURAMAN S, RAMALINGAM N, ERNST M, NAU R, LANGE C, KÖSTERS K, GNANAMUTHU C, JOHN GT, MARSHALL B, LALVANI A. Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific Tcells. Int J Tuberc Lung Dis 2008; 12: 651-657.
83. JINKINS JR. Computed tomography of intracranial tuberculosis. Neuroradiology 1991; 33: 126-135.
84. JINKINS JR, GUPTA R, CHANG KH, CARBAJAL JR. MR imaging of central nervous system tuberculosis. Radiol Clin North Am 1995; 33: 771-786.
85. ANDRONIKOU S, SMITH B, HATHERHILL M, WILMSHURST J. Definitive neuroradiological diagnostic features of tuberculous meningitis in children. Pediatr Radiol 2004; 34: 876-885.
86. OZTOPRAK I, GÜMÜS C, OZTOPRAK B, ENGIN A. Contrast medium-enhanced MRI findings and changes over time in stage I tuberculous meningitis. Clin Radiol 2007; 62: 1206-1215.
87. NAIR PP, KALITA J, KUMAR S, MISRA UK. MRI pattern of infarcts in basal ganglia region in patients with tuberculous meningitis. Neuroradiology 2009; 51: 221-225.
88. VILLORIA MF, DE LA TORRE J, FORTEA F, MUNOZ L, HERNANDEZ T, ALAR ON JJ. Intracranial tuberculosis in AIDS: CT and MRI findings. Neuroradiology 1991; 34: 11-14.
89. WHITEMAN M, ESPINOSA L, DONOVAN POST MJ, BELL MD, FALCONE S. Central nervous system tuberculosis in HIV-infected patients: clinical and radiographic findings. Am J Neuroradiol 1995, 16: 1319-1327.
90. GREEN C, HUGGETT JF, TALBOT E, MWABA P, REITHER K, ZUMLA AI. Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods. Lancet Infect Dis 2009; 9: 505-511.
91. PITCHENIK AE, BURR J, SUAREZ M, FERTEL D, GONZALEZ G, MOAS C. Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed: a prospective study. Am Rev Respir Dis 1987; 135: 875-879.
92. THEUR CP, HOPEWELL PC, ELIAS D, et al. Human immune deficiency virus infection in tuberculosis patients. J Infect Dis 1990; 162: 8-12.
93. BISHBURG E, SUNDERAM G, REICHMAN LB, KAPILA B. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med 1986; 105: 210-213.
94. BERENGUER J, MORENO S, LAGUNA F, VICENTE T, ADRADOS M, ORTEGA A, GONZÁLEZ-LAHOZ J, BOUZA E. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992; 326: 668-672.
95. MAHER D, RAVIGLIONE M. Global epidemiology of tuberculosis. Clin Chest Med 2005; 26: 167-182.
96. SCHNEIDER E, MOORE M, CASTRO KG. Epidemiology of tuberculosis in the United States. Clin Chest Med 2005; 26: 183-195.
97. BARNES PF, BLOCH AB, DAVIDSON PT, SNIDER DE Jr: Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324: 1644.
98. CORBETT EL, WATT CJ, WALKER N, MAHER D, WILLIAMS BG, RAVIGLIONE MC, DYE C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
99. THWAITES GE, DUC BANG N, HUY DUNG N, THI QUY H, THI TUONG OANH D, THI CAM THOA N, QUANG HIEN N, TRI THUC N, NGOC HAI N, THI NGOC LAN N, NGOC LAN N, HONG DUC N, NGOC TUAN V, HUU HIEP C, THI HONG CHAU T, PHUONG MAI P, THI DUNG N, STEPNIEWSKA K, SIMMONS CP, WHITE NJ, TINH HIEN T, FARRAR JJ. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192: 2134-2141.
100. LAGUNA F, ADRADOS M, ORTEGA A, GONZALEZ-LAHOZ JM. Tuberculous meningitis with acellular cerebrospinal fluid in AIDS patients. AIDS 1992; 6: 1165-1167.
101. KARSTAEDT AS, VALTCHANOVA S, BARRIERE R, CREWE-BROWN HH. Tuberculous meningitis in South African urban adults.Q J Med 1998; 91: 743-747.
102. DUBE MP, HOLTOM PD, LARSEN RA. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 1992; 93: 520-524.
103. LAMMIE GA, HEWLETT RH, SCHOEMAN JF, DONALD PR. Tuberculous cerebrovascular disease: A review. J Infect 2009; 59: 156-166.
104. HUMPHRIES MJ, TEOH R, LAU J, GABRIEL M. Factors of prognostic significance in Chinese children with tuberculous meningitis. Tubercle 1990; 71: 161-68.
105. SCHAAF HS, MARAIS BJ, WHITELAW A, HESSELING AC, ELEY B, HUSSEY GD, DONALD PR. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infect Dis 2007; 7: 140.
106. MITCHISON DA. Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis 2000; 4: 796-806.
107. THWAITES GE, LAN NT, DUNG NH, QUY HT, OANH DT, THOA NT, HIEN NQ, THUC NT, HAI NN, BANG ND, LAN NN, DUC NH, TUAN VN, HIEP CH, CHAU TT, MAI PP, DUNG NT, STEPNIEWSKA K, WHITE NJ, HIEN TT, FARRAR JJ. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192: 79-88.
108. THWAITES GE, NGUYEN DB, NGUYEN HD, HOANG TQ, DO TT, NGUYEN TC, NGUYEN QH, NGUYEN TT, NGUYEN NH, NGUYEN TN, NGUYEN NL, NGUYEN HD, VU NT, CAO HH, TRAN TH, PHAM PM, NGUYEN TD, STEPNIEWSKA K, WHITE NJ, TRAN TH, FARRAR JJ. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351: 1741-1751.
109. DONALD PR, SCHOEMAN JF, VAN ZYL LE, DE VILLIERS JN, PRETORIUS M, SPRINGER P. Intensive shor t course chemotherapy in the management of tuberculous meningitis. Int J Tuberc Lung Dis 1998; 2: 704-711.
110. THWAITES G, FISHER M, HEMINGWAY C, SCOTT G, SOLOMON T, INNES J. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009; 59: 167-187.
111. WORLD HEALTH ORGANIZATION. Treatment of tuberculosis: guidelines for national programmes, 3rd edn. Geneva, Switzerland: World Health Organization, 2002.
112. BLUMBERG HM, BURMAN WJ, CHAISSON RE, DALEY CL, ETKIND SC, AMERICAN THORACIC SOCIETY, CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE INFECTIOUS DISEASES SOCIETY. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
113. PRASAD K, SINGH MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008; Art. No.: CD002244.
114. ROCK RB, HU S, GEKKER G, SHENG WS, MAY B, KAPUR V, PETERSON PK. Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone. J Infect Dis 2005; 192: 2054-2058.
115. ROCK RB, OLIN M, BAKER CA, MOLITOR TW, PETERSON PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008; 21: 243-261.
116. THWAITES GE, MACMULLEN-PRICE J, TRAN TH, PHAM PM, NGUYEN TD, SIMMONS CP, WHITE NJ, SUMMERS D, FARRAR JJ. Serial MRI to determine the eff ect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 2007; 6: 230-236.
117. GREEN JA, TRAN CT, FARRAR JJ, NGUYEN MT, NGUYEN PH, DINH SX, HO ND, LY CV, TRAN HT, FRIEDLAND JS, THWAITES GE. Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS ONE 2009; 4: e7277.
118. GREEN JA, ELKINGTON PT, PENNINGTON CJ, RONCAROLI F, DHOLAKIA S, MOORES RC, BULLEN A, PORTER JC, AGRANOFF D, EDWARDS DR, FRIEDLAND JS. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-B- and activator protein-1-dependent monocyte networks. J Immunol 2010; 184, 6492-6503.
119. NICOLLS DJ, KING M, HOLLAND D, BALA J, DEL RIO C. Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect Dis 2005; 5: 795-801.
120. LU CH, CHANG WN, CHANG HW. The prognostic factors of adult tuberculous meningitis. Infection 2001; 29: 299-304.
121. ROCK RB, OLIN M, BAKER CA, MOLITOR TW, PETERSON PK. Central nervous system tuberculosis: pathogenesis and clinical aspects. Clin Microbiol Rev 2008; 21: 243-261.
122. WANG JT, HUNG CC, SHENG WH, WANG JY, CHANG SC, LUH KT. Prognosis of tuberculous meningitis in adults in the era of modern antituberculous chemotherapy. J Microbiol Immunol Infect 2002; 35: 215-222.
123. MISRA UK, KALITA J, SRIVASTAVA M, MANDAL SK. Prognosis of tuberculous meningitis: a multivariate analysis. J Neurol Sci 1996; 137: 57-61.
124. MEDICAL RESEARCH COUNCIL. Streptomycin treatment of tuberculous meningitis. Lancet 1948; I: 582-596.
125. HSU PC, YANG CC, YE JJ, HUANG PY, CHIANG PC, LEE MH. Prognostic factors of tuberculous meningitis in adults: a 6-year retrospective study at a tertiary hospital in Northern Taiwan. J Microbiol Immunol Infect 2010; 43: 111-118.
126. THWAITES GE, NGUYEN DB, NGUYEN HD, HOANG TQ, DO TT, NGUYEN TC, NGUYEN QH, NGUYEN TT, NGUYEN NH, NGUYEN TN, NGUYEN NL, NGUYEN HD, VU NT, CAO HH, TRAN TH, PHAM PM, NGUYEN TD, STEPNIEWSKA K, WHITE NJ, TRAN TH, FARRAR JJ. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351: 1741-1751.
127. RODRIGUES LC, DIWAN VK, WHEELER JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993; 22: 1154-1158.
128. STERLING TR, MARTIRE T, DE ALMEIDA AS, DING L, GREENBERG DE, MOREIRA LA, ELLOUMI H, TORRES AP, SANT'ANNA CC, CALAZANS E, PARAGUASSU G, GEBRETSADIK T, SHINTANI A, MILLER K, KRITSKI A, LAPA E SILVA JR, HOLLAND SM. Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination. Pediatrics 2007; 120: e912-21.
129. COLDITZ GA, BREWER TF, BERKEY CS, WILSON ME, BURDICK E, FINEBERG HV, MOSTELLER F. Effi cacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698-702.
130. NEWTON SM, BRENT AJ, ANDERSON S, WHITTAKER E, KAMPMANN B. Paediatric tuberculosis. Lancet Infect Dis 2008; 8: 498-510.
131. MÖLLER M, HOAL EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis 2010; 90: 71-83.
132. STANFORD JL. Improving on BCG. APMIS 1991; 99: 103-113.
133. XIAO-YAN YANG, QUN-FEI CHEN, XIAO-HUA CUI et al. Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: A meta-analysis. J Infect 2010; 60: 320-330.
134. WHO-IUTALD GLOBAL PROJECT ON ANTI-TUBERCULOSIS DRUG RESISTANCE SURVEILLANCE. Anti-tuberculosis drug resistance in the world (report No. 4). Available from: http://www.who.int/tb/publications/2008/drs-report4-26feb08.pdf.
135. WHO MEDIA REPORT. WHO global task force outlines measures to combat XDRTB worldwide. Available from: http://www.who.int/mediacentre/news/notes/2006/np29/ en/index.html
136. VAN DEN BOOGAARD J, KIBIKI G, KISANGA ER, BOEREE MJ, AARNOUTSE RE. New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. Antimicrob Agents Chemother 2009; 53: 849-862.
137. GINSBERG AM. Tuberculosis drug development: progress, challenges, and the road ahead. Tuberculosis 2010; 90: 162-167.